Raynaud's phenomenon as adverse effect of amphotericin B;ZYANOTISCHES RAYNAUD-PHANOMEN ALS NEBENWIRKUNG VON AMPHOTERICIN B

Klinische Padiatrie

Volumn 208, Issue 2, 1996, Pages 53-55

  Zernikow, Boris ^a   Fleischhack, Gudrun ^a   Hasan, Carola ^a   Bode, Udo ^a,b  

^a Abt Padiatrische Hamatologie Oncol   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Adverse effect of Amphotericin B; Raynaud's phenomenon

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CYTARABINE; ETOPOSIDE; HYDROXYUREA; IDARUBICIN; IMIPENEM; IPRATROPIUM BROMIDE; ITRACONAZOLE; PROSTAGLANDIN SYNTHASE INHIBITOR; TEICOPLANIN; TERBUTALINE; TIOGUANINE; ANTIFUNGAL AGENT;

ADOLESCENT; CASE REPORT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MALE; MYCOSIS; ORAL DRUG ADMINISTRATION; RAYNAUD PHENOMENON; SHORT SURVEY; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANDIDIASIS; CHEMICALLY INDUCED DISORDER; ISCHEMIA; LUNG MYCOSIS; OPPORTUNISTIC INFECTION; TOE; VASCULARIZATION;

ADOLESCENT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CANDIDIASIS; HUMANS; ISCHEMIA; LEUKEMIA, MYELOCYTIC, ACUTE; LUNG DISEASES, FUNGAL; MALE; OPPORTUNISTIC INFECTIONS; RAYNAUD DISEASE; TOES;

EID: 0029878834     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043994     Document Type: Short Survey

References (14)

1. Adler-Moore, J. P., R. T. Proffitt: Entwicklung. Charakterisierung, Wirksamkeit und Wirkmodus von Ambisome, einer unilamellaren Liposom-Formulierung von Amphotericin B. J. Liposome Res. 3 (1993) 429-450
2. Aguado, J. M., M. Hidalgo, I. Moya, J. M. Alvazar, M. J. Jimenez, A. R. Noriega: Ventricular arrhythmias with conventional and liposomal amphotericin (letter). Lancet 342 (1993) 1239
3. Bennett, J. M., D. Catovsky, M. T. Daniel, G. Flandrin, D. A. G. Galton, H. R. Gralnick, C. Sultan: Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med. 103 (1985) 626-629
4. Bodey, G. P., E. J. Anaissie, L. S. Elting, E. Estey, S. O'Brien, H. Kantarjian: Antifungal prophylaxis during remission induction therapy for acute leukemia. Fluconazole versus intravenous Amphotericin B. Cancer 73 (1994) 2099-2106
5. Eppes, S. C., J. L. Troutman, L. T. Gutman: Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr. Infect. Dis. J. 8 (1989) 99-104
6. Hardie, W. D., J. Ebert, M. Frazer, K. Takahashi, K. Badr: The effect of thromboxane A2 receptor antagonist on Amphotericin B induced renal vasoconstriction. Prostaglandins 45 (1993) 47-56
7. Heidrich, H.: Das Raynaud-Syndrom. Deutsches Ärzteblatt 90 (1993) 25-30
8. Hertenstein, B., W. V. Kern, T. Schmeiser, M. Stefanic, D. Bunjes, M. Wiesneth, J. Novotny, H. Heimpel, R. Arnold: Low incidence of invasive fungal infections after hone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol 68 (1994) 21-26
9. Heyman, S. N., B. A. Clark, N. Kaiser, F. H. Epstein, K Spokes, S. Rosen, M. Brezis: In-vivo and in-vitro studies on the effect of amphotericin B on endotheline release. J. Antimicrob. Chemother. 29 (1992) 69-77
10. McDonnell, T. J., S. W. Chang, J. Y. Westcott, N. F. Voelkel: Role of oxidants, eicosanoids, and neutrophils in amphotericin B lung injury in rats. J. Appl. Physiol. 65 (1988) 2195-2206
11. Omizo, M. K, R. E. Bryant, M. O. Loveless: Amphotericin B-induced malignant hypertension (letter). Clin. Infect. Dis. 17 (1993) 817-818
12. Reiner, N. E., W. L. Thompson: Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs. J. Infect. Dis. 140 (1979) 564-575
13. Soupart, A., G. Decaux: Nifedipine and amphotericin B nephrotoxicity in the rat. Nephron 52 (1989) 278-280
14. Sawaya, B. P., H. Weihprecht, W. R. Champbell, J. N. Lorenz, R. C. Webb, J. P. Briggs, J. Schnermann: Direct vasoconstriction as a possible cause for amphotericin B induced nephrotoxicity in rats. J. Clin. Invest. 87 (1991) 2097-2107